Plasma PPi Deficiency Is the Major, but Not the Exclusive, Cause of Ectopic Mineralization in an Abcc6-/- Mouse Model of PXE
- PMID: 28652107
- PMCID: PMC7069658
- DOI: 10.1016/j.jid.2017.06.006
Plasma PPi Deficiency Is the Major, but Not the Exclusive, Cause of Ectopic Mineralization in an Abcc6-/- Mouse Model of PXE
Abstract
Pseudoxanthoma elasticum (PXE), a prototype of heritable ectopic mineralization disorders, is caused in most cases by inactivating mutations in the ABCC6 gene. It was recently discovered that absence of ABCC6-mediated adenosine triphosphate release from the liver and consequently reduced plasma inorganic pyrophosphate (PPi) levels underlie PXE. This study examined whether reduced levels of circulating PPi, an antimineralization factor, is the sole mechanism of PXE. The Abcc6-/- and Enpp1asj mice were crossed with transgenic mice expressing human ENPP1, an ectonucleotidase that generates PPi from adenosine triphosphate. We generated Abcc6-/- and Enpp1asj mice, either wild-type or hemizygous for human ENPP1. Plasma levels of PPi and the degree of ectopic mineralization were determined. Overexpression of human ENPP1 in Enpp1asj mice normalized plasma PPi levels to that of wild-type mice and, consequently, completely prevented ectopic mineralization. These changes were accompanied by restoration of their bone microarchitecture. In contrast, although significantly reduced mineralization was noted in Abcc6-/- mice expressing human ENPP1, small mineralization foci were still evident despite increased plasma PPi levels. These results suggest that PPi is the major mediator of ectopic mineralization in PXE, but there might be an alternative, as yet unknown mechanism, independent of PPi, by which ABCC6 prevents ectopic mineralization under physiologic conditions.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
CONFLICTS OF INTEREST
JPS has a research contract with BIOCON LLC that has nothing to do with this project. All other authors declare no conflicts of interest.
Figures



Similar articles
-
ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.Int J Mol Sci. 2021 Apr 27;22(9):4555. doi: 10.3390/ijms22094555. Int J Mol Sci. 2021. PMID: 33925341 Free PMC article. Review.
-
Inhibition of Tissue-Nonspecific Alkaline Phosphatase Attenuates Ectopic Mineralization in the Abcc6-/- Mouse Model of PXE but Not in the Enpp1 Mutant Mouse Models of GACI.J Invest Dermatol. 2019 Feb;139(2):360-368. doi: 10.1016/j.jid.2018.07.030. Epub 2018 Aug 18. J Invest Dermatol. 2019. PMID: 30130617 Free PMC article.
-
Novel treatment for PXE: Recombinant ENPP1 enzyme therapy.Mol Ther. 2024 Nov 6;32(11):3815-3820. doi: 10.1016/j.ymthe.2024.09.028. Epub 2024 Sep 27. Mol Ther. 2024. PMID: 39342427
-
INZ-701, a recombinant ENPP1 enzyme, prevents ectopic calcification in an Abcc6-/- mouse model of pseudoxanthoma elasticum.Exp Dermatol. 2022 Jul;31(7):1095-1101. doi: 10.1111/exd.14587. Epub 2022 May 16. Exp Dermatol. 2022. PMID: 35511611 Free PMC article.
-
Pseudoxanthoma Elasticum as a Paradigm of Heritable Ectopic Mineralization Disorders: Pathomechanisms and Treatment Development.Am J Pathol. 2019 Feb;189(2):216-225. doi: 10.1016/j.ajpath.2018.09.014. Epub 2018 Nov 7. Am J Pathol. 2019. PMID: 30414410 Free PMC article. Review.
Cited by
-
Adenovirus-Mediated ABCC6 Gene Therapy for Heritable Ectopic Mineralization Disorders.J Invest Dermatol. 2019 Jun;139(6):1254-1263. doi: 10.1016/j.jid.2018.12.017. Epub 2019 Jan 11. J Invest Dermatol. 2019. PMID: 30639429 Free PMC article.
-
A Fragile Phosphate/Pyrophosphate Balance: From Essential Mineralization to Rare Calcifying Diseases.Curr Osteoporos Rep. 2025 Aug 6;23(1):34. doi: 10.1007/s11914-025-00928-z. Curr Osteoporos Rep. 2025. PMID: 40768170 Review.
-
ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.Int J Mol Sci. 2021 Apr 27;22(9):4555. doi: 10.3390/ijms22094555. Int J Mol Sci. 2021. PMID: 33925341 Free PMC article. Review.
-
Mutation update: Variants of the ENPP1 gene in pathologic calcification, hypophosphatemic rickets, and cutaneous hypopigmentation with punctate keratoderma.Hum Mutat. 2022 Sep;43(9):1183-1200. doi: 10.1002/humu.24391. Epub 2022 May 18. Hum Mutat. 2022. PMID: 35475527 Free PMC article. Review.
-
Bone Marrow-Derived ABCC6 Is an Essential Regulator of Ectopic Calcification In Pseudoxanthoma Elasticum.J Invest Dermatol. 2024 Aug;144(8):1772-1783.e3. doi: 10.1016/j.jid.2024.01.026. Epub 2024 Feb 15. J Invest Dermatol. 2024. PMID: 38367909 Free PMC article.
References
-
- Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 2000;25:228–31. - PubMed
-
- Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000;92:1295–302. - PubMed
-
- Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42:1007–17. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous